Evidence map›Paper›PMID 14627435›Full record

ArticleThe Biochemical journal2004

Differences in regulatory properties between human and rat glucokinase regulatory protein.

Katy J Brocklehurst, Rick A Davies, Loranne Agius

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Biochemical journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. From genetic association to molecular mechanism.Current diabetes reports · 2010
    Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Katy J BrocklehurstCardiovascular and Gastrointestinal Department, AstraZeneca, Macclesfield, Cheshire SK10 4TG, UK.
Rick A Davies
Loranne Agius
AstraZeneca (United Kingdom) · GBNewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inhibition of glucokinase by rat and Xenopus GKRPs (glucokinase regulatory protein) is well documented. We report a comparison of the effects of human and rat GKRPs on glucokinase activity. Human GKRP is a more potent inhibitor of glucokinase than rat GKRP in the absence of fructose 6-phosphate or sorbitol 6-phosphate, and has a higher affinity for these ligands. However, human and rat GKRPs have similar affinities for fructose 1-phosphate and chloride. Residues that are not conserved between the rodent and human proteins affect both the affinity for fructose 6-phosphate and sorbitol 6-phosphate and the inhibitory potency of GKRP on glucokinase in the absence of these ligands.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarrier ProteinsChloridesEnzyme InhibitorsFructosephosphatesGlucokinaseGlucoseHexosephosphatesHumansIntracellular Signaling Peptides and ProteinsKineticsLigandsRatsSpecies SpecificityAdaptor Proteins, Signal TransducingCarrier ProteinsChloridesEnzyme Inhibitorsfructose-1-phosphatefructose-6-phosphateFructosephosphatesGCKR protein, humanGckr protein, ratGlucokinaseglucokinase regulatory proteinGlucoseHexosephosphatesIntracellular Signaling Peptides and ProteinsLigandssorbitol 6-phosphate

Identifiers

PMID14627435
PMCPMC1223974
OpenAlexW2010834491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.